Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabian Maass
Observed names:
F. Maass,
Maass, Fabian
Institutions:
Universitätsmedizin Göttingen,
University of Göttingen
Observed institutions:
German Cancer Research Center,
Universitätsmedizin Göttingen,
Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103,
Universitätsmedizin Rostock,
DKFZ-ZMBH Alliance,
University of Rostock,
University of Göttingen
show all 7
ORCID:
0000-0002-4077-2852
Observed ORCID:
0000-0002-4077-2852
OpenAlex ID:
A5024577973
Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
2018
·
Anna Elisa Roser
, Lucas Caldi Gomes
, et al.
·
Frontiers in Neuroscience
·
127
PDF
Noncoding Transcripts in Sense and Antisense Orientation Regulate the Epigenetic State of Ribosomal RNA Genes
2010
·
H. Bierhoff
, K. Schmitz
, et al.
·
Cold Spring Harbor Symposia on Quantitative Biology
·
109
PDF
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
2019
·
Karina Joppe
, Anna-Elisa Roser
, et al.
·
Frontiers in Neuroscience
·
103
PDF
Lifelong Caloric Restriction Increases Working Memory in Mice
2013
·
Angela Kuhla
, Sophie Lange
, et al.
·
PLoS ONE
·
95
PDF
Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease – A pilot study
2019
·
Matthias Boerger
, Sebastian Funke
, et al.
·
Parkinsonism & Related Disorders
·
89
Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
2020
·
Fabian Maass
, Sebastian Rikker
, et al.
·
Scientific Reports
·
65
PDF
Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis
2020
·
Jan C. Koch
, Josua Kuttler
, et al.
·
Frontiers in Neurology
·
55
PDF
miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons
2018
·
Anna-Elisa Roser
, Lucas Caldi Gomes
, et al.
·
Molecular Therapy — Nucleic Acids
·
54
PDF
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease
2018
·
Fabian Maass
, Bernhard Michalke
, et al.
·
Journal of Neurochemistry
·
51
PDF
Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease
2022
·
Lucas Caldi Gomes
, Ana Galhoz
, et al.
·
Clinical and Translational Medicine
·
46
PDF
Cerebrospinal fluid biomarker for Parkinson's disease: An overview
2018
·
Fabian Maass
, Isabel Schulz
, et al.
·
Molecular and Cellular Neuroscience
·
44
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
2019
·
Maria Angela Samis Zella
, Judith Metzdorf
, et al.
·
Cells
·
43
PDF
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
2019
·
Fabian Maass
, Bernhard Michalke
, et al.
·
Neurobiology of Disease
·
41
PDF
Detection of Prion Protein Seeding Activity in Tear Fluids
2023
·
Matthias Schmitz
, Susana Silva Correia
, et al.
·
New England Journal of Medicine
·
35
Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson’s disease
2019
·
Fabian Maass
, Bernhard Michalke
, et al.
·
Journal of Trace Elements in Medicine and Biology
·
32
Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann–Pick Type C1 mice
2013
·
M. Hovakimyan
, F. Maass
, et al.
·
Neuroscience
·
32
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
2021
·
Sezgi Canaslan
, Matthias Schmitz
, et al.
·
Frontiers in Aging Neuroscience
·
22
Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: A mouse model of Niemann‐Pick type C1 disease
2014
·
Fabian Maass
, Jana Petersen
, et al.
·
Journal of Neuroscience Research
·
21
MicroRNAs from extracellular vesicles as a signature for Parkinson's disease
2021
·
Lucas Caldi Gomes
, Anna‐Elisa Roser
, et al.
·
Clinical and Translational Medicine
·
20
PDF
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
2024
·
Asuncion Carmona
, Eleonora Carboni
, et al.
·
Journal of Neurochemistry
·
19
PDF
Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease
2022
·
Matthias Schmitz
, Sezgi Canaslan
, et al.
·
Molecular Neurobiology
·
18
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
2022
·
Pretty Garg
, Fabian Maass
, et al.
·
Molecular and Cellular Neuroscience
·
17
Cerebrospinal Fluid Iron‐Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease
2021
·
Fabian Maass
, Bernhard Michalke
, et al.
·
Movement Disorders
·
15
PDF
Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies
2021
·
Niels Hansen
, Claudia Lange
, et al.
·
Brain Sciences
·
14
PDF
Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions
2024
·
Fabian Maass
, Sezgi Canaslan
, et al.
·
Journal of Neurology
·
13
PDF
Show more works
View as search
Works count:
66
Citation count:
1,258
H-index:
19
I10-index:
27
Year
Topic
Type